American Century Companies’s Catalyst Pharmaceutical CPRX Stock Holding History

American Century Companies's CPRX Position: Q1 2026 in Review

American Century Companies increased its Catalyst Pharmaceutical (CPRX) stake by 37% in Q1 2026, buying an estimated $26.5M and bringing the position to 4,138,416 shares worth $102M. The position accounts for 0.05% of the portfolio, ranked #415.

American Century Companies first reported a position in CPRX in Q2 2020 and has held it in 24 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

• American Century Companies held 4,138,416 shares of Catalyst Pharmaceutical worth $102M as of Q1 2026.
• American Century Companies bought 1,113,145 Catalyst Pharmaceutical shares in Q1 2026, an estimated $26.5M.
• Catalyst Pharmaceutical made up 0.05% of American Century Companies's portfolio in Q1 2026, its #415 holding.
• American Century Companies first reported a position in Catalyst Pharmaceutical in Q2 2020 and has held it in 24 quarters since.
• 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.